330 related articles for article (PubMed ID: 30466971)
1. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
2. Biotechnological interventions in Withania somnifera (L.) Dunal.
Singh P; Guleri R; Singh V; Kaur G; Kataria H; Singh B; Kaur G; Kaul SC; Wadhwa R; Pati PK
Biotechnol Genet Eng Rev; 2015; 31(1-2):1-20. PubMed ID: 25787309
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
5. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
6. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
8. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
9. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
10. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
11. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
12. Virus-Induced Silencing of Key Genes Leads to Differential Impact on Withanolide Biosynthesis in the Medicinal Plant, Withania somnifera.
Agarwal AV; Singh D; Dhar YV; Michael R; Gupta P; Chandra D; Trivedi PK
Plant Cell Physiol; 2018 Feb; 59(2):262-274. PubMed ID: 29165715
[TBL] [Abstract][Full Text] [Related]
13. Critical factors influencing in vitro propagation and modulation of important secondary metabolites in
Kaur K; Dolker D; Behera S; Pati PK
Plant Cell Tissue Organ Cult; 2022; 149(1-2):41-60. PubMed ID: 35039702
[No Abstract] [Full Text] [Related]
14. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
16. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
17. A Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway Engineering.
Dhar N; Razdan S; Rana S; Bhat WW; Vishwakarma R; Lattoo SK
Front Plant Sci; 2015; 6():1031. PubMed ID: 26640469
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptome analysis of different chemotypes elucidates withanolide biosynthesis pathway from medicinal plant Withania somnifera.
Gupta P; Goel R; Agarwal AV; Asif MH; Sangwan NS; Sangwan RS; Trivedi PK
Sci Rep; 2015 Dec; 5():18611. PubMed ID: 26688389
[TBL] [Abstract][Full Text] [Related]
19. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A
Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336
[TBL] [Abstract][Full Text] [Related]
20. Leaf spot disease adversely affects human health-promoting constituents and withanolide biosynthesis in Withania somnifera (L.) Dunal.
Singh V; Singh B; Sharma A; Kaur K; Gupta AP; Salar RK; Hallan V; Pati PK
J Appl Microbiol; 2017 Jan; 122(1):153-165. PubMed ID: 27709727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]